Secondary Prophylaxis of Docetaxel Induced Diarrhea with Loperamide: Case Report
Journal of Korean Medical Science
; : 1549-1551, 2013.
Article
Dans En
| WPRIM
| ID: wpr-155942
Responsable en Bibliothèque :
WPRO
ABSTRACT
Diarrhea is a common adverse event of docetaxel with 20%-40% of incidence and severe diarrhea occurs in 5%-6%. Several treatment guidelines for chemotherapy induced diarrhea (CID) exist, however the prophylaxis for that is not well known. We describe a new prophylactic approach for the CID with loperamide. A 72-yr-old male patient with stage IV non-small-cell lung cancer developed diarrhea repeatedly after docetaxel-cisplatin chemotherapy. His diarrhea persisted despite treatment including loperamide and fasting. However, the diarrhea was successfully prevented when loperamide was given before and after the chemotherapy. To our knowledge, this is the first report of prophylactic approach for the CID with loperamide.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Tomodensitométrie
/
Cisplatine
/
Carcinome pulmonaire non à petites cellules
/
Taxoïdes
/
Diarrhée
/
Association de médicaments
/
Lopéramide
/
Tumeurs du poumon
/
Stadification tumorale
Type d'étude:
Guideline
Limites du sujet:
Aged
/
Humans
/
Male
langue:
En
Texte intégral:
Journal of Korean Medical Science
Année:
2013
Type:
Article